- Featured Product
- KD/KO Validated
GALNT4 Polyklonaler Antikörper
GALNT4 Polyklonal Antikörper für WB, IHC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, IHC, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 12897-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
12897-1-PBS bindet in WB, IHC, Indirect ELISA GALNT4 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | GALNT4 fusion protein Ag3590 |
| Vollständiger Name | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4) |
| Berechnetes Molekulargewicht | 578 aa, 67 kDa |
| Beobachtetes Molekulargewicht | 67 kDa |
| GenBank-Zugangsnummer | BC036390 |
| Gene symbol | GALNT4 |
| Gene ID (NCBI) | 8693 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
GALNT4 is a member of N-acetylgalactosaminyltransferases (GALNTs) which are responsible for initiating step of mucin-type O-glycosylation. Desregulation of GALNTs expression can exert pivotal functions during malignant transformation. It has been reported that GALNT4 expression is markedly repressed in tumoral tissues and lower expression of GALNT4 is significant associated with the adverse survival, indicating its potential role as prognostic factor for cancers like hepatocellular carcinoma.



